Physician profile
Nancy E Shoji
NPI 1538139464
$2,091.55
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $108 · 2020: $169 · 2021: $1,126 · 2022: $14.47 · 2023: $486 · 2024: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $674.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $928.51 | 2019-2024 | Total30 |
| Johnson & Johnson Vision Care, INC. | $567.59 | 2019-2024 | Acuvue |
| Astellas Pharma US INC | $167.19 | 2023-2024 | Izervay |
| Bausch & Lomb Americas INC. | $85.83 | 2023 | Infuse |
| Allergan, INC. | $84.00 | 2020 | |
| Coopervision INC. | $74.13 | 2023 | Misight Contact Lens |
| Carl Zeiss Meditec USA, INC. | $56.25 | 2024 | Cirrus Hd-Oct |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.30 | 2019-2020 | |
| Optos, INC. | $30.53 | 2019-2022 | |
| Rxsight INC | $25.42 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Shoji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.